
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
Click the title above for a link to open the Pharmaceutical Commerce February 2024 issue in an interactive PDF format.
over 2 years ago
The Value of 3PLsover 2 years ago
New Year, New Aspirationsover 2 years ago
Access Insights and Information Aboundover 2 years ago
A Look at the Medicare 'Extra Help' Programover 2 years ago
Who Moved My Prescription? Part IIover 2 years ago
The Path for Prescription Drug Salesover 2 years ago
The Impact of 340B on Commercial Contractsover 2 years ago
DSCSA 2024 or 2023 Déjà Vu?





